Lemini LA, Cruz FED, Gamboa JTI, Hernández PF, Pérez CAE, Arreola RRL, Valverde GYA, Durón VD, Mejía MCG, Franco PMV, Juárez AFG, Flores PG, Eligio ÁM, Aguilar UMA, Castellanos PLG, Hop GK, Anides FAE

Language: Spanish
References: 11
Page: 228-233
PDF size: 354.58 Kb.

ABSTRACT

Skin manifestations due to sars-cov-2 have been reported in different countries. In Mexico, it has been published that urticaria and maculopapular rashes are the most frequent associated dermatosis.
Objetive: to describe the cutaneous manifestations and their histopathological characteristics in Mexican patients with sarscov- 2 infection at the Hospital de Especialidades, Centro Médico Nacional Siglo xxi, imss from March 15, 2020 to October 15, 2020.
Material and methods: We carried out a retrospective, cross-sectional and descriptive study of patients diagnosed with covid-19 who were hospitalized in the covid area. Patients older than 18 years were included, with a positive test for sarscov- 2, who presented a dermatological manifestation and skin biopsy was performed for histopathological studies with hematoxylin- eosin and immunohistochemistry for c4d and langerina.
Results: twelve patients with covid-19 associated dermatosis who underwent skin biopsy were included. In 50% they were localized-dermatoses with a greater affection to the lower limbs, characterized by purpuric dermatoses in half of the cases.
Conclusions: the clinical-pathological correlation could not be established, not the association between proinflammatory and thrombotic laboratory indicators with histopathology due to the reduced sample size. Even so, our study provides both clinical and histopathological characteristics in patients hospitalized for severe covid.

REFERENCES

1. Singhal T, A review of coronavirus disease-2019 (covid-19), Indian J Pediatr 2020; 87(4):281-6.

2. Recalcati S, Cutaneous manifestations in covid-19: a first perspective, J Eur Acad Dermatol Venereol 2020; 34(5):e212-3.

3. Zhang Y, Cao W, Xiao M, Li YJ, Yang Y, Zhao J et al., Clinical and coagulation characteristics of 7 patients with critical covid-2019 pneumonia and acro-ischemia, Zhonghua Xue Ye Xue Za Zhi 2020;41(0):E006.

4. Bouaziz JD, Duong TA, Jachiet M, Velter C, Lestang P, Cassius C et al., Vascular skin symptoms in covid-19: a French observational study, J Eur Acad Dermatol Venereol 2020; 10.1111/jdv.16544.

5. Galván Casas C, Català A, Carretero Hernández G, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa Lario A et al., Classification of the cutaneous manifestations of covid-19: a rapid prospective nationwide consensus study in Spain with 375 cases, Br J Dermatol 2020;183(1):71-7.

6. Rodríguez-Cerdeira C, Uribe-Camacho BI, Silverio-Carrasco L, Méndez W, Mahesh AR, Tejada A, Beirana A et al., Cutaneous manifestations in covid-19: report on 31 cases from five countries, Biology (Basilea) 2021; 10(1):54.

7. Welsh EC, Alfaro Sánchez AB, Ortega Gutiérrez GL, Cárdenas-de la Garza JA, Cuéllar-Barboza A, Valdés-Espinosa RA et al., covid-19 dermatological manifestations: results from the Mexican Academy of Dermatology covid-19 registry, Int J Dermatol 2021.

8. Cepeda-Valdés R, Carrión-Álvarez D, Trejo-Castro A, Hernández- Torre M y Salas-Alanís J, Cutaneous manifestations in covid-19: familial cluster of urticarial rash, Clin Exp Dermatol 2020:10.1111/ced.14290.

9. Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J et al., Complement associated microvascular injury and thrombosis in the pathogenesis of severe covid-19 infection: a report of five cases, Transl Res 2020; 220:1-13.

10. Kaya G, Kaya A y Saurat JH, Clinical and histopathological features and potential pathological mechanisms of skin lesions in covid-19: review of the literature, Dermatopathology (Basilea) 2020; 7(1):3-16.

11. Gianotti R, Zerbi P y Dodiuk-Gad RP, Clinical and histopathological study of skin dermatoses in patients affected by covid-19 infection in the Northern part of Italy, J Dermatol Sci 2020; 98(2):141-3.